Multidisciplinary Oral Management in Cancer Therapy Part II: During Cancer Treatment
Keywords:
Interceptive therapy, Oral prophylaxis, Salivary substitute, Xerostomia.Abstract
One of the most important patients-related variables is the patient
References
Sicilia A, Arrequi I, Gallego M, Cabezas B, Cuesta S. Home oral hygiene revisited. Options and advice. Oral Health Preventive Dent, Vol.1, pp 407-422, 2003.
Laing E, Ashley P, Gill D, Naini F. An Update on oral hygiene products and Techniques. Dental Update, Vol.35, pp 270-279, 2008.
Jones LR, Toth BB, Keene HJ, Effects of total body irradiation on salivary gland function and caries associated oral microflora in bone marrow transplant patients. Oral Surg, Oral Med, Oral Pathol, Radiol Endod, Vol. 86, pp 286-92, 1998.
Epstein JB, Chin EA, Jacobson JJ, Rishiraj B, Le N. The relationships among fluoride, cariogenic oral flora, and salivary flow rate during radiation therapy. Oral Srug Oral Med Oral Pathol Oral Radiol Endod, Vol. 86, pp 286-92, 1998.
Kielbassa A, Hinkelbein W, Hellwig E, Meyer-Luckel H. Radiation-related damage to dentition. Lancet Oncol, Vol. 7, pp 326-335, 2006.
Aguiar GP, Jham BC, Magalhaes CS, Sensi LG, Freire AR. A review of the biological and clinical aspects of radiation caries. J Contemp Dent Pract, Vol. 10(4), pp 83-89, 2009.
Meurman JH, Gronroos L. Oral and dental health care of oral cancer patients: hyposalivation, caries and infections. Oral Oncology, Vol. 46, pp. 464-467, 2010.
Barclay SC, Turani D. Current Practice in Dental Oncology in the UK. Dental Update, Vol. 37, pp. 555- 561, 2010.
Ramirez-Amador V., Silverman, S. Jnr., Mayer, P, Tyler, M, Quivey, J. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg, Oral Med, Oral Pathol, Radiol Endod, Vol. 84, pp.149-153, 1997.
Lalla R, Latortue M, Hong C Ariyawardana A, D
Stockman MA, Spijkervet FKL, Boezen HM, Schouten JP, Roodenburg JLN, de Vries EGE. Prevention Intervention Possibilities in Radiotherapy- and Chenotherapy-induced Oral Mucositis: results of Meta- analyses J Dent Res, Vol. 85(8), pp 690-700, 2006.
Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, RAber-Durlacher JE, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer, Vol. 109(5), pp. 820-31, 2007..
Epstein, JB., Silverman S,Jr., Paggiarino DA, Crockett S, Schubert MM, Senzer NN, et al. Benzydamine HCL for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer, Vol. 92(4), pp 875-85, 2001.
Treister N, Sonis S. Mucositis: biology and management. Otolarygol Head Neck Surg, Vol. 15, pp123- 129, 2007.
Brizel DM, Overgaard J.Does amifostine have a role in chemoradiation treatment? Lancet Oncology, Vol. 4, pp.593, 2003.
Ship, J.A., Eisbruch, A., D
Chambers MS, Rosenthal DI, Weber RS. Radiation-induced xerostomia. Head and Neck, Vol. 29: pp 58- 63, 2007.
Eisbruch A. Reducing xerostomia by IMRT: what may, or may not, be achieved. J Clin Oncol, Vol. 25, pp 4862-4, 2007.
Jensen SB, Pedersen A, Vissink A, Andersen E, Brown C et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer, Vol.18, 2010.
Nieuw Amerongen AV, Veerman ECI. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer, Vol.11, pp.226-231, 2003.
Downloads
Published
How to Cite
Issue
Section
License
Authors who submit papers with this journal agree to the following terms.
